Lean more about the European Heart Rhythm Association: https://www.escardio.org/EHRA

Current Designation: Senior Consultant ,Critical Care Medicine Apollo Hospitals, Bhubaneswar MD ( Anaesth), DNB,EDIC ( London) ,FICCM Advanced Training Critical Care , Australia • More than 17 years experience in Critical Care Area of Expertise: NeuroCritical Care, Polytrauma, Sepsis and Ventilation Infection Control and Nutrition Society and Academics * EC member, Indian Society Of Critical Care Medicine, ( 2020-22) * EC Member Elect, Indian Society Of Critical Care Medicine, ( 2022-24) * Member of SCCM Other Highlights: Around 65 guest lectures and 16 publications in indexed journals and book chapters. Reviewer national and international journals. Presentations at national and international meetings ( Critical Care Congress and Brussels meet ).…

Courtesy of KSA in partnership with Glenmark Pharma. Topic: Peri-operative Management of Anticoagulants Speaker: Dr. Ian Odari

ACC AHA Guidelines 2020 | Anticoagulants and Antiplatelets | Dr. Nik Nikam VKA, DOAC, clopidogrel, aspirin, bleeding, embolic risk, duration, dual, triple, therapy, DVT, VTE, PE, value, anticoagulants, Channel dedicated to heart health education ACC AHA ESC #Guidelines are explained and simplified for bedside management. Dr. Nik, Dr. Nikam, academy, university, clinic, Mayo, Cleveland, Khan, ACC, AHA, ESC,, guidelines, update, seminars, board, review, pptx, grand, rounds, clinic, college, JOHNS, HOPKINS, CRAM, MED, lectures, simplified, explained, nursing, ancc, aprn, np, apn, pci, hf, hfref, hfpef, Houston, medical, center, methodist, memorial, chi, hca, va, college, school, vascular, center, Cooley, Debakey, JNC, Houston, Texas, st., luke's, TMC, JACC, ish, #cardiology, #cardiologynurse, #cardiologist #internists, #primarycare, #primarycarephysician, #medicalstudent, #medicalresident, #cardiologyfellow, #criticalcaremedicine, #cardiologynp, #nursepractitioner, #icunurse, #acc, #americanheartassociation, #CME, Please subscribe to this NNN channel by clicking the subscribe button. Host: NIK NIKAM, MD, MHA | drniknikam@gmail.com | 281-745-4161 IMPORTANT DISCLAIMER: The information contained in my videos is for general education only and is not a professional advice or recommendation. Please consult with your professional advisers before you make any decisions. Join our Google+: https://plus.google.com/u/0/+NikNikam/posts Like our Facebook Page https://www.facebook.com/pages/NIK-NIKAM-Network-NNN/465844610205062?ref=hl NANO NEWS NETWORK - NNN MEDIA Cardiology, heart health, public education

ACC AHA GUIDELINE 2020 ANTIPLATELETS AND ANTICOAGULANTS Dr Nik Nikam DR. Nik, Dr. Nikam, acc, aha, guidelines, stents, VKA, doac, clopidogrel, asa, ticagrelor, p2Y12, antiplatelet, agents, anticoagulants, ACC, AHA, GUIDELINES simplified for bedside management. Dr. Nik, Dr. Nikam, academy, university, clinic, Mayo, Cleveland, Khan, ACC, AHA, ESC,, guidelines, update, seminars, board, review, pptx, grand, rounds, cdc, fda, clinic, college, medical, internists, cardiologist, fellows, students, residents, primary care, medicine, internal, JOHNS, HOPKINS, CRAM, MED, lectures, simplified, explained, nursing, ancc, aprn, np, apn, pci, hf, hfref, hfpef, houston, medical, center, methodist, memorial, chi, hca, va, college, school, #cardiology, #cardiologynurse, #cardiologist #internists, #primarycare, #primarycarephysician, #medicalstudent, #medicalresident, #cardiologyfellow, #criticalcaremedicine, #cardiologynp, #nursepractitioner, #icunurse, #acc, #americanheartassociation, Channel dedicated to heart health education Please subscribe to this NNN channel by clicking the subscribe button. Host: NIK NIKAM, MD, MHA | drniknikam@gmail.com | 281-745-4161 IMPORTANT DISCLAIMER: The information contained in my videos is for general education only and is not a professional advice or recommendation. Please consult with your professional advisers before you make any decisions. Join our Google+: https://plus.google.com/u/0/+NikNikam/posts Like our Facebook Page https://www.facebook.com/pages/NIK-NIKAM-Network-NNN/465844610205062?ref=hl NANO NEWS NETWORK - NNN MEDIA Cardiology, heart health, public education

Direct Oral Anticoagulants for Atrial Fibrillation with Roy Kim, MD

👉📝WANT STUDY NOTES FOR THIS PRESENTATION? 👉Join Patreon at https://www.patreon.com/speedpharmacology Anticoagulants, commonly referred to as blood thinners, are drugs that prevent or reduce coagulation of blood, prolonging the clotting time. Antiplatelet drugs, also known as a platelet aggregation inhibitors, decrease platelet aggregation and inhibit clot formation. These drugs play an important role in the treatment of various disorders such as myocardial infarction, thrombotic stroke and venous thromboembolism. This pharmacology lecture covers topics such as pathophysiology of blood clot formation and platelet function; activation, aggregation, cross-linking; ADP receptors, glycoprotein IIb/IIIa receptors, cyclooxygenase-1 (COX-1) enzyme, fibrinogen, fibrin mesh, coagulation cascade; intrinsic & extrinsic pathways, clotting factors, antithrombin, heparin induced thrombocytopenia, INR, plasmin, and plasminogen; mechanism of action of platelet inhibitors, anticoagulants, thrombolytic agents, and drugs used for treatment of bleeding. Drugs mentioned include; Aspirin, Clopidogrel, Ticagrelor, Ticlopidine, Prasugrel, Abciximab, Eptifibatide, Tirofiban, Heparin, low molecular weight heparins; Enoxaparin, Dalteparin, Protamine sulfate, Apixaban, Rivaroxaban, Univalent & Bivalent direct thrombin inhibitors; Argatroban, Dabigatran, Bivalirudin, Desirudin, Warfarin, Vitamin K, Alteplase, Reteplase, Tenecteplase, Urokinase, Streptokinase, Aminocaproic acid, Tranexamic acid. Thanks for watching and don't forget to SUBSCRIBE, hit the LIKE button👍 and click the BELL button🔔 for future notifications!!! 0:00 Platelet plug formation 2:04 Platelet aggregation inhibitors 5:34 Coagulation cascade 7:38 Anticoagulants 12:03 Warfarin 14:11 Thrombolytics

The Perioperative Anticoagulant Use for Surgery Evaluation (PAUSE) study is the largest to date that addresses how to manage patients with atrial fibrillation who are receiving perioperative direct oral anticoagulants. Here, James Douketis, MD, of McMaster University, Hamilton, ON, Canada, presents the results of the study at the American Society of Hematology (ASH) 2018 Annual Meeting and Exposition in San Diego, CA, which have the potential to be practice-changing.

Dr.P.P.Mohanan at WCCPCI 2015

Dr. Alan Jacobson is a pioneer and leader in the field of anticoagulation management, having implemented innovative strategies within the VA system to improve anticoagulation management and dramatically reducing risk with out-of-range INR and complications associated with anticoagulation therapy. Dr. Jacobson will address the challenges associated with the new therapeutic drugs, which require less monitoring, but bring new risks. There are new lessons being learned that can help keep patients safer when these innovative new medications are being used. Following his presentation, a reactor panel will discuss the new information shared by Dr. Jacobson.

Dr. PP Mohanan Director and HOD of Cardiology,Westfort Hi-Tech Hospital Thrissur, Kerala For more videos click on https://therightdoctors.com... Download TheRightDoctors app : https://play.google.com/store/apps/details?id=com.therightdoctors.app TheRightDoctors, a Google Launchpad Digital Health StartUp, is one of the leaders in production and dissemination of Medical Information. We bring Insights from the World's Best Medical Minds to digital audiences worldwide across leading digital and social media platforms. Subscribe for more videos: https://www.youtube.com/..... Our Social Media Links : Facebook - https://goo.gl/YO1oel Google + - https://goo.gl/ImMXq5 Twitter - https://goo.gl/J1gtvw LinkedIn - https://goo.gl/FClkyl

In this short audio snippet, you'll hear our PL experts debate the pros and cons of the new oral anticoagulants -- when to use these agents instead of warfarin -- and how to choose between them.

Following the lectures series on the updates in Pharmacy, Shifa Center of Professional Excellence (SCOPE) in collaboration with Shifa International Hospitals Ltd, Islamabad has organized the Fourth webinar on the "Anticoagulation with Direct Oral Anticoagulants (DOACs)". Muhammad Awais, Clinical Pharmacist, Certified Anti-coagulation, Management Pharmacist. U.S.I (USA), Shifa International Hospitals Ltd. discussed Anticoagulation with Direct Oral Anticoagulants (DOACs) briefly and answered questions live. #SCOPE #Training #Development #Islamabad #Pakistan #shifacenterofprofessionalexcellence #webinar #education #worldwide #ContinuingEducation #continuingmedicaleducation #CME #shifainternationalhospital #ShifaFoundation #covid19

This presentation by Trevor Baglin was originally given at the ISTH 2013 Congress in Amsterdam. For more information and to download slides, click here: https://academy.isth.org/isth/2013/amsterdam/31778/trevor.baglin.the.role.of.the.laboratory.in.treatment.with.new.oral.html?f=topic=5212*media=1 For more presentations like this, access the ISTH Academy: https://academy.isth.org

New anticoagulants in renal patients: practical aspects. Prof. Hamza Kabil 38 th Annual Congress of the Egyptian Society of Nephrology and Transplantation 19-22 Feb 2020

Department of Medicine Grand Rounds presentation by Drs. Kelley Branch and Jeffrey Probstfield, Department of Medicine, Division of Cardiology University of Washington School of Medicine

Lecture delivered on June 17, 2010. This is the first Distinguished Lecture in Immunology supported by Bristol-Myers Squibb. UC Irvine Institute For Immunology presents Michael D. Cahalan, Ph.D., Professor and Chair Department of Physiology and Biophysics Institute for Immunology University of California, Irvine.

Bristol-Myers Squibb Co (BMY) Q2 2020 Earnings Report https://news.alphastreet.com/earnings-bristol-myers-squibb-company-nyse-bmy-reports-q2-2020-results/

Dr. Giovanni Caforio, Bristol Myers Squibb CEO, joins the 'Halftime Report' to discuss his company's collaboration with Century Therapeutics. For access to live and exclusive video from CNBC subscribe to CNBC PRO: https://cnb.cx/2NGeIvi  » Subscribe to CNBC TV: https://cnb.cx/SubscribeCNBCtelevision » Subscribe to CNBC: https://cnb.cx/SubscribeCNBC Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide. The News with Shepard Smith is CNBC’s daily news podcast providing deep, non-partisan coverage and perspective on the day’s most important stories. Available to listen by 8:30pm ET / 5:30pm PT daily beginning September 30: https://www.cnbc.com/2020/09/29/the-news-with-shepard-smith-podcast.html?__source=youtube%7Cshepsmith%7Cpodcast    Connect with CNBC News Online Get the latest news: http://www.cnbc.com/ Follow CNBC on LinkedIn: https://cnb.cx/LinkedInCNBC Follow CNBC News on Facebook: https://cnb.cx/LikeCNBC Follow CNBC News on Twitter: https://cnb.cx/FollowCNBC Follow CNBC News on Instagram: https://cnb.cx/InstagramCNBC https://www.cnbc.com/select/best-credit-cards/  #CNBC #CNBCTV

This special meeting on Women Inspiring a Peaceful & Sustainable Future was hosted by CSPOC at United Nations of Geneva. The event was directed and curated by Kristin Engvig and produced by GCF & WIN. GCF and WIN have worked together since 2019 and their women pioneering global change initiative includes the 16th May 2022 and the 11th May 2023 meeting in Geneva. It will conclude in New York in 2024

Introduction by: Thomas Lynch, MD, CEO, Mass General Physician's Organization Moderator: Meg Tirrell, Biotech and Pharma Reporter, CNBC Giovanni Caforio, MD, CEO, Bristol-Myers Squibb

As organizations move more workloads to the cloud, they have a growing need for security and governance. Cloud teams are asked to use new AWS Regions and services while meeting the compliance needs of the business. In this session, Bristol Myers Squibb, a leading global life sciences company, dives deep into how they have implemented a fully automated self-service platform. Learn how they enabled self-service for all business users, centrally managed network and data resources, and automated governance. Also learn how they used AWS Control Tower and AWS Service Catalog to support controls and deliver best practice kits in their cloud environment. (GRC-202) Learn more about AWS re:Inforce at https://bit.ly/3baitIT. Subscribe: More AWS videos http://bit.ly/2O3zS75 More AWS events videos http://bit.ly/316g9t4 ABOUT AWS Amazon Web Services (AWS) hosts events, both online and in-person, bringing the cloud computing community together to connect, collaborate, and learn from AWS experts. AWS is the world’s most comprehensive and broadly adopted cloud platform, offering over 200 fully featured services from data centers globally. Millions of customers—including the fastest-growing startups, largest enterprises, and leading government agencies—are using AWS to lower costs, become more agile, and innovate faster. #reInforce2022 #CloudSecurity #AWS #AmazonWebServices #CloudComputing

Krishna Cheriath sits down with Dave Vellante for a digital CUBE Conversation as part of the MIT CDOIQ 2020 Symposium

E. Jay Wilusz, Senior Corporate Counsel, Bristol Myers Squibb AI continues to increase the speed and efficiency of the entire bandwidth of pharmaceutical interests. Those interests include drug discovery, clinical data processing, and digital interfaces between patients and providers to improve treatment outcomes. How should nascent and established companies protect their AI and ML intellectual property assets? I will describe how to balance patent protection or secrecy agreements against the need to publicize technology improvements, technology lifespan, and the ability to monitor for infringement and defend IP rights.

The increasing amount of data available to pharmaceutical companies creates pressure on R&D teams to orchestrate and analyze that data and generate insights that will help patients prevail over serious diseases. In this session, learn how Bristol-Myers Squibb used AWS services to create a platform-based approach for ingesting, preparing, curating, and persisting business-critical data for digital integration, analytics, and insights generation. Hear how this approach has improved the company’s efficiency, enhanced cost savings, and decreased the time-to-service for its data customers. Additionally, gain an understanding of the lessons learned from this process, and learn best practices for other organizations.

29 Mar 2021 - Immutep Limited (ASX:IMM, NASDAQ:IMMP) CEO and Executive Director Marc Voigt talks about the Bristol Myers Squibb trial evaluating Anti-LAG-3 Antibody Relatlimab and Opdivo (nivolumab) in patients with previously untreated metastatic or unresectable melanoma, meeting its primary endpoint of progression-free survival and what it means for Immutep.

Kristen Hege, M.D., is Senior Vice President, Early Clinical Development, Hematology/Oncology & Cell Therapy, at Bristol Myers Squibb. At Benchling’s virtual launch event, Dr. Hege discussed her 30+ year hybrid academic/industry career in cell therapy, from the emergence of the field during the AIDS crisis in the ‘90s, to incredible outcomes in patients with blood cancers in the 2010s, and the approval of the first BCMA CAR T product in 2021. —————————— Benchling is the pioneer of the R&D Cloud, software that powers the biotechnology industry. More than 200,000 scientists at over 600 companies and 7,000 research institutions globally have adopted Benchling’s R&D Cloud to make breakthrough discoveries and bring the next generation of medicines, food, and materials to market faster than ever before. The R&D Cloud helps these organizations modernize their scientific processes and accelerate collaboration so they can convert the complexity of biology into world-changing results. To learn more, visit https://www.benchling.com/

Mohammad Shaikh, Bristol Myers Squibb Oleg Moiseyenko, Bristol Myers Squibb June 11, 2020 - Virtual https://irods.org/ugm2020

Shall Chadha, Sr. Technology Services Lead, Accenture & Kathleen Netriello, Vice President and Head of IT Digital Design, Bristol Myers-Squibb sit down with Rebecca Knight t the AWS Executive Summit at AWS re:Invent. #AWS #theCUBE #AWSSummit https://siliconangle.com/2018/12/27/cloud-ai-services-dose-big-pharma-with-overdue-speed-agility-reinvent/ Cloud AI services dose big pharma with overdue speed, agility What industry could stand to pick up its pace more than pharmaceutical research? Look at the price of drugs in the U.S. It can take over 10 years and billions of dollars to develop one pill. Providing insight and historical context, modern machine-learning technologies could make pharma a more efficient industry. Bristol-Myers Squibb Co. is adopting cloud technologies to speed up research into immuno-oncology therapies. These treatments boost the immune system in order to fight cancer. “Our highest priority was our scientists’ productivity,” said Kathleen Natriello (pictured, right), vice president of corporate information technology at Bristol-Myers Squibb. BMS has teamed up with Amazon Web Services Inc. and Accenture LLP to develop solutions for its scientists and business units. Genomics research requires huge volumes of data. With machine learning and artificial intelligence services from AWS, BMS scientists have drastically reduced the time it takes to process them. Natriello and Shalu Chadha (pictured, left), technology lead, products North East North America, at Accenture, spoke with Rebecca Knight (@knightrm), host of theCUBE, SiliconANGLE Media’s mobile livestreaming studio, during the AWS Executive Summit in Las Vegas. They discussed how the three-way partnership is injecting speed and agility into typically glacier-paced pharma processes. (* Disclosure below.) It’s about time for agility in pharma BMS has implemented several AWS cloud services that enable scientists to use AI for computational approaches and simulations. They slash the time and cost required to complete an experiment, according to Natriello. “They no longer have to use actual physical material or patients or investigators. They can do it all through simulation and modelling,” she said. It uses AI-powered robotics process automation across legal and compliance, and is now starting to use them in clinical trials. It is trying to become “quicker with how the patients are going to see both responses to adverse events, as well as how do you accelerate the clinical trial process,” Chadha said. Scientists are the biggest advocates for the introduction of new tech, according to Natriello. “They are doing things with machine learning and artificial intelligence with these simulations … in a few hours that used to take them weeks and months,” she stated. Business functions are enthusiastically on-board as well. “Very often, the business functions are the ones that introduce the new technologies, because they’re really interested in it,” Natriello concluded. Watch the complete video interview below, and be sure to check out more of SiliconANGLE’s and theCUBE’s coverage of the AWS Executive Summit. (* Disclosure: TheCUBE is a paid media partner for the AWS Executive Summit event. Neither Accenture LLP, the event sponsor, nor other sponsors have editorial control over content on theCUBE or SiliconANGLE.)

Sign up for our next summit for free here: https://bit.ly/PTFSummit Bristol Myers Squibb recognizes and celebrates the diverse experiences and views of their workforce. They encourage every employee to bring their authentic selves to work so they can fully engage in a meaningful way and drive the company's mission to help patients prevail over serious diseases. Bristol Myers Squibb's PRIDE Alliance is a vital part of that effort, helping to ensure a diverse and inclusive culture that empowers LGBTQ+ inclusion, awareness, and engagement. For this roundtable discussion, we are joined by several BMS leaders to share their career journeys and take a deep dive into BMS's Heath Equity approach and work including how prior partnerships with HIV and LGBTQ+ communities became the playbook for the current initiatives. PowerToFly's Meg Alexander will moderate. Sign up for our next summit for free here: https://bit.ly/PTFSummit

On April 21st, Bristol Myers Squibb joined ACP in hosting a "Careers At BMS" webinar for interested veteran and military spouse Protégés. The event featured a panel of BMS employees who spoke about company culture, job opportunities, and their own personal transitions from the military to Corporate America. The event closed with a Q&A session from the 85-person virtual audience. Many thanks to Marty, Pat, Ricardo, Kristen and Marissa for a terrific event!

Compere Jonathan McCrea speaks with MIke Furlong, Executive DIrector, Cruiserath Biologics, BMS, Mairead Looby, Director, Manufacturing Science and Technology, BMS, Donagh Walls, Associate Director, QC Site Operations, BMS, and Lisa Cahill, HR Manager, BMS.

Latin-American GLAM and MDSF Symposium 2021 MDS SATELLITE SYMPOSIUM (English) Bristol Myers Squibb Company Low Risk MDS, new therapeutic strategies Chairman: Alicia Enrico (ARG) Speaker: Guillermo García Manero (USA)

Steve Goldman discusses how to have a safe, effective drill for your hospital or healthcare facility. Due to the new CMS Emergency Preparedness Guidelines set to be in full effect by November 2017, many emergency planners are looking at ways to improve their drills. Steve has lots of ideas to reviewing and improving your drills to ensure everyone is safe during an incident.

IPC London Sunday Message by Guest speaker Pastor Thomas Philip Venmany (IPC General Joint Secretary)

Music video for On Va Piétiner ft KOFFI OLOMIDE performed by Bebi philip. https://www.youtube.com/channel/UCcVJuyx_vU96hlCMD4zm_Ig https://instagram.com/bebi.philip.5 https://itunes.apple.com/fr/artist/bebi-philip/id425092975 Copyright (C) 2016 BBP Team Records. --- Powered by http://www.vydia.com http://vevo.ly/P9BrDU

Subscribe to the Disaster Empire Website newsletter and follow my blogs at: www.disasterempire.com Ashley Goosman's LinkedIn Profile: www.linkedin.com/in/ashley-goosman Dr. Steve's Profile - linkedin.com/in/dr-steve-goldman-5668844 Crisis Management and Business Resiliency, Advanced Business Resiliency: web.mit.edu/professional/short-programs/courses/crisis_management.html Consulting: SteveGoldmanAssociates.com (Company) More link's to a sampling of Ashley's works: DRJ Career Spotlight: Career Spotlight – https://drj.com/journal_main/career-spotlight-ashley-goosman/ Business Continuity Institute (BCI): Engaging with others is invaluable for your career: https://www.thebci.org/news/engaging-with-others-is-invaluable-for-your-career-interview-with-ashley-goosman.html Continuity Insights: https://continuityinsights.com/the-end-of-business-continuity-as-we-know-it/ If you are interested in sponsoring an upcoming video, being a guest on the channel, or partnering on future blogs, contact me at info@disasterempire.com #massachusettsinstituteoftechnology #education #certification #crisismanagement #resilience #businessresilience #businesscontinuity

'Ek Bhram Sarvagun Sampanna' actress Tina Philip recently postponed her wedding with fiance Nikhil Sharma due to Coronavirus outbreak and she shares how the feeling was like and what precautions she is taking currently. Watch the video to know more. #TinaPhilip #NikhilSharma #SarvagunSampanna

Scottish Communities Climate Action Network General Assembly 13 September 2020 Our community’s chance to steer our support and decide SCCAN’s priority for activities. We explored: Storytelling, Podcasts, Regional Gatherings, Local Zero Carbon Plans, Governance skills and Fundraising. Our keynote speaker is Davie Philip - a Scottish activist who's been advocating for sustainable community in Ireland for over 20 years. He hosts events and facilitates groups - working on collaborative approaches to help their localities flourish - through Cultivate, the trading name of the Sustainable Ireland Cooperative Society he co-founded in 2000. Davie - based at WeCreate, an ecosystem of innovation in Cloughjordan Ecovillage - has served on the Council of ECOLISE, the European network for community-led initiatives on climate change and sustainability for 4 years. He was elected as an ECOLISE co-president - along with Francesca Whitlock of Global Ecovillage Network (GEN) Europe - in 2019. We heard Davie Philip's Presentation on grassroots empowerment in tackling the Climate and Ecological Emergency. Davie is a Scottish activist who's been advocating for a sustainable community in Ireland for over 20 years. He facilitates groups working on collaborative approaches to help localities flourish - through Cultivate, the trading name of the Sustainable Ireland Cooperative Society he co-founded in 2000. Read the full event's report here: https://bit.ly/sccanga13sept Communities for Future website: https://events.communitiesforfuture.org/ http://www.cultivate.ie/about-cultivate-new/our-people http://www.resilience.cultivate.ie/ Scottish Communities Climate Action Network - a network of community groups and organisations taking action on climate change. Our Purpose: To inspire and promote, connect and support community-led action in Scotland to address the Climate Emergency https://www.scottishcommunitiescan.org.uk/

Taking a pet's temperature and having that information automatically added to their medical record would be a huge efficiency gain. This week, Shawn & Ivan chat with Yale Zhang of Mella Pet Care about innovations in workflow through connected devices. Yale recommends Smart People Should Build Things by Andrew Yang (amzn.to/3eq76Kv). Learn more about Yale at mella.ai. 👉 Mentioned in This Episode: - Launching a New Startup With the Same Team - Connecting Medical Devices to Practice Management Software - Creating Devices for Both Veterinarians and Pet Parents Our website: https://www.veterinaryinnovationpodcast.com/ Subscribe: Apple Podcasts - https://apple.co/2Y9joNR Google Podcasts - http://bit.ly/2X36dMZ Google Play - http://bit.ly/2XxdskI Spotify - https://spoti.fi/2KzSw6x Stitcher - http://bit.ly/2Y4ZK5H

Mark Sullivan, mark.f.sullivan@state.ma.us MA Office of International Trade & Investment (MOITI), https://www.mass.gov/orgs/massachusetts-office-of-international-trade-and-investment .. SelectUSA Summit, 1-4 May 2023, Washington, DC https://www.selectusasummit.us/ -- Feel free to contact us with any questions Bill Kenney, bill@meetroi.com MEET, http://meetroi.com/

Mark Sullivan, Chief Growth Officer & Partner of Stonehaven its down with ACG NY during the 15th Annual Healthcare Conference. The event assembled over 450 senior Middle Market Healthcare payers, providers, systems as well as top private equity, family office and strategic buyers representing billions of dollars ready to invest in the North American Healthcare Sector.

Join us as we talk technology, digital currency, and business with Mark Sullivan - EVP at Salesforce https://www.thepavementgroup.com/

Data is widely accepted as an asset, the drive has begun to get the maximum return from it. Hear Mark Sullivan - Global CFO, IDC talk about Data Monetization with Reema Tendulkar on CNBC TV18's TECH @ work. ---------------------------------------------------------------------------------------- Follow IDC India on LinkedIn https://bit.ly/2H1Da8v & Twitter https://bit.ly/2TdBwHf for more updates.

In the future, the limiting factor will be available space. The Founders of SPLT draw from their personal experiences in creating their transportation platform and talk about the direction of the shared economy and how that will help reduce waste, increase sustainability, and bring about the shared transportation platforms of tomorrow. -- Anya Babbitt is the Founder & CEO. She has started multiple businesses and exited one. Anya is resilient, resourceful and a quick decision maker. Having written her thesis on the Kyoto Protocol, Anya is driven to work with cities, corporations and universities to align integrated services thereby reformatting cities of the future. Under Anya's leadership, SPLT has been recognized for 40+ awards and prizes such as the Hult Prize, Google Demo Day, Clean Energy Trust, and Accelerate Michigan as well as press in Huffington Post, Forbes and TechCrunch. SPLT has expanded to serve organizations in the United States, Latin America, and now Europe. Anya is passionate about social responsibility and environmental impact to create a more livable and breathable world with mobility access for all. Yale Zhang, Co-Founder, comes from a background in transportation and logistics, focusing on the warehousing and distribution of physical goods around the United States. He exited a multimillion dollar healthcare products distribution company. In his capacity as Vice President of Wintao Global, they secured multi-year software development contracts with major transportation companies including Dynamex, Datatrac, Marc Global (now a subsidiary of RedPrairie). This talk was given at a TEDx event using the TED conference format but independently organized by a local community. Learn more at https://www.ted.com/tedx

Yale Zhang is the founder of hardware start-up Safe Heart, which develops innovative wellness applications, hardware, and accessories. Their flagship product iOximeter is the first pulse oximeter to work on Android and iOS platforms, and a recent finalist on the Engadget Insert Coin competition. The iOximeter is a vital signs monitoring tool for smart phones. It is powered through the phone audio jack. Current features of the app include measurements of the oxygen saturation and heart rate, recording, and alarm functionality. Presentation will go over the conception, research, development, and commercialization of the iOximeter product. Future functionality road map will be revealed. A Q&A session will be held afterwards. The presentation will conclude with a live demo and a device giveaway.

WCX TV sits down with Yale Zhang, Co-Founder of SPLT, to learn about the work that SPLT is doing regarding shared mobility.

By: Jake Voorhees https://www.youtube.com/jakevoorhees Anya Babbitt is the Founder and CEO of Splitting Fares, Inc. (“SPLT”), an enterprise ridesharing platform changing the way people commute together. Ms. Babbitt is a marketing and brand strategist dedicated to fresh insights, authentic messaging and measurable results in sustainability. An experienced entrepreneur, Anya has founded and grown three successful companies and exited one. Anya Babbitt is not your typical entrepreneur. Number one, she is a women in a tech start-up, number two, she is the CEO and number three she is working in an area (transportation) that is dominated by men. Anya, however, is not concerned about the gender inequality or the odds of success–she is laser focused on changing the way people meet and move in urban environments. As a German immigrant, her great grandfather achieved enough success in the United States that he was able to send his five sons to Princeton Prep School and consequently to Princeton University. As a result, Anya believes that the United States provides the best opportunities for innovation and entrepreneurship. She understands and appreciates the supportive environment that allows and encourages her to build and scale her world-changing venture. Anya hopes to inspire other women to pursue entrepreneurship and contribute to creating jobs and socially innovative ventures. Anya has guided SPLT from a small startup in NYC to being chosen for Techstars Mobility 2015 driven by Detroit. Her professional experience spans over 15 years working in the advertising, corporate communications, marketing, product design and sales sector primarily in Boston and New York City, including several years engaged in corporate brand development for multiple brands in domestic and worldwide locations. As a marketing entrepreneur, Anya has successfully provided marketing strategies to such notable institutions and luxury brands as WilmerHale (formerly Hale & Dorr), Trilogy Capital Partners, the Winter Equestrian Festival (WEF), Vicomte A., Hermes, Cartier, Bombardier, Fraser Yachts, L’Oreal, Maybach, the Vicente Fox Center of Studies, Library and Museum, Citizens Energy Corporation and the international and domestic Polo Clubs Association. She has led large teams of individuals working under tight deadlines and with large committed budgets. Her ability to plan ahead and execute under pressure allowed her to excel within the closely tied luxury goods market creating clients out of partnership opportunities. Throughout her career she has been engaged in testing the connection between purpose driven leadership and competitive bottom line performance. As a result, her teams have consistently outperformed peers in both growth and profitability. Since 2014, she has devoted her full attention to the emerging field of social and environmental sustainability, launching SPLT. Yale Zhang is a co-founder of Splitting Fares, Inc. Prior to entering the world of entrepreneurship, Yale’s background was in transportation and logistics, focusing on the warehousing and distribution of physical goods around the United States. In his capacity as Vice President of Wintao Global, they secured multi-year software development contracts with major transportation companies including Dynamex, Datatrac, Marc Global (now a subsidiary of RedPrairie). The insight into these transportation entities allowed Yale to leave and in 2007 start Clinical Guard, his first product distribution company, in medical supplies. The company has grown from an initial annual revenue of $400K to now $3M. Later, he started a medical device innovations company, Safe Heart USA, Inc, focused on creating vital signs monitoring hardware that works in coordination with smartphones running Android and iOS. As the CEO of Safe Heart, Yale has overseen the successful commercialization of research from Oxford University, Emory University, the successful raising of grants from the Atlantic Pediatric Device Consortium, and finally, in raising capital to initially fund a newly emerging business venture. Although Yale has achieved a certain level of success with his involvement in medical devices, his primary passion has always been transportation systems, specifically autonomous vehicles. Yale believes that ongoing technology research by many private and public companies will lead to car ownership reduction as vehicles become autonomous. When that happens, extraordinary opportunities arise for people to share vehicles. He joins SPLT with the intent to help change the behavior of people so that they are comfortable with sharing rides with other people so that everyone will be ready when the autonomous vehicle economy arrives.

PTSD and Pain - A presentation by Dr. Mark Sullivan at the Oregon Pain Guidance conference: 4th Annual Thoughtful Approach to Chronic Pain: New Horizons, What Clearly Works